Contents
Key findings
- 1"FDA-approved" is a fact about a decision on a specific product for a specific use; "proven effective" is a judgement about the strength of evidence for a specific claim. They are different questions.
- 2An approved drug can be used off-label with weak evidence, and an unapproved compound can have strong or weak evidence — approval and evidence do not move together.
- 3Non-approval usually means no company submitted adequate trials, not that a compound was tested and failed.
- 4The four combinations — approved-and-proven, approved-but-unproven-for-this-use, unapproved-but-promising, unapproved-and-untested — all exist among the peptides we cover.
- 5Reading any health claim well means asking both questions separately, every time.
Evidence level
This is a definitional explainer. The distinction between regulatory status and evidence quality is standard in evidence-based medicine and in FDA's own framework; the peptide examples are graded on their own profile pages.
Regulatory status
The regulatory categories described here come from FDA statute and guidance. Each peptide named carries its own status on its profile.
Most arguments about peptides - and about health products generally - come down to one confusion: treating "FDA-approved" and "proven to work" as the same statement. They are answers to two different questions, and once you separate them, almost every claim becomes easier to read.
Two questions, not one
Question one: what has the FDA decided? This is a regulatory fact. A company submitted evidence for a specific product and a specific use; the FDA reviewed it and either approved that use or did not. You can look it up in a database[1]. It is binary and checkable.
Question two: how strong is the evidence? This is a scientific judgement about a specific claim - how good, how large, how consistent the human studies are. It is a spectrum, not a yes/no, which is why this site uses six evidence levels.
These questions are related but independent. Approval is based on evidence, so a newly approved drug usually has strong evidence for its approved use. But the moment you ask about a different use, or a compound no company has submitted, the two come apart.
Why they come apart
Approval is granted for a specific use. The FDA approves a drug for an indication after reviewing trials designed to test it[3]. That approval says nothing about other uses. A prescriber may legally use an approved drug "off-label" for something else, but that use was not reviewed and its evidence may be thin[2].
Non-approval is usually silence, not failure. When a compound is "not FDA-approved," the most common reason is that no company ran the large, expensive trials and submitted them - not that it was tested and rejected. Absence of approval is absence of a submission, which is different from evidence of failure.
Some things never needed approval. Food ingredients and cosmetics are regulated under different rules. Collagen peptides have randomised human trials and no drug approval - because as a food they were never in the drug-approval lane at all.
The four combinations, with real examples
Every box in this grid is occupied by a peptide we cover. That is the whole point.
| Strong human evidence | Weak or no human evidence | |
|---|---|---|
| FDA-approved (for this use) | Established evidenceSemaglutide for weight management - approved, and backed by large trials | Rare: approval generally follows evidence |
| Not FDA-approved for this use | Promising evidenceCollagen peptides for skin - not a drug, but has randomised trials | Preclinical evidenceBPC-157 for healing - unapproved and no controlled human trials |
Approved and proven: semaglutide. FDA-approved for chronic weight management, and supported by trials in thousands of people. Both questions answer "yes." See the semaglutide profile.
Approved for one use, thin for another: tesamorelin. FDA-approved to reduce visceral fat in HIV-associated lipodystrophy, on phase 3 evidence. Used off-label for general fat loss, where the evidence is far weaker. Same drug, two very different answers to question two depending on the use. See the tesamorelin profile.
Unapproved but has some evidence: collagen peptides. Not a drug, so no approval applies - yet multiple randomised trials support modest skin and joint benefits. "Not FDA-approved" here means "not a drug," not "unproven." See the collagen peptides profile.
Unapproved and untested: BPC-157. Not FDA-approved, and no controlled human trials for the healing benefits it is sold for. Here both questions answer "no" - which is very different from the collagen case, even though both are "not FDA-approved." See the BPC-157 profile.
How to use this on any claim
When you read that a peptide is "FDA-approved," ask: approved for what, exactly? The indication is the whole meaning.
When you read that one is "clinically proven," ask: proven for which claim, in whom, with what quality of study?
And when you read that one is "not FDA-approved," ask the follow-up that actually matters: is that because it was tested and failed, because no one submitted trials, or because it isn't a drug at all? Those are three completely different situations wearing the same three words.
Where to go next
- Evidence levels explained - the six-level scale and how we assign it.
- FDA-approved, off-label, investigational and unapproved peptides - the regulatory categories in depth.
- Are peptides worth it? - applying both questions to a buying decision.
- Peptide benefits: what the evidence supports
Frequently asked questions
- Does "FDA-approved" mean a drug works?
- It means the FDA reviewed evidence for a specific use and judged the benefits outweigh the risks for that use. It is strong evidence of effectiveness for the approved indication - but not for other uses the same drug might be put to.
- Does "not FDA-approved" mean a compound doesn't work?
- No. It usually means no company has submitted adequate trials for review, often because none exist. Non-approval is not a finding that something failed; it is the absence of a positive finding.
- Can something be proven effective but not FDA-approved?
- It is uncommon for a genuinely proven treatment to have no approval, because approval follows the evidence. But food ingredients (like collagen peptides) can have trial evidence without needing drug approval, since they are not regulated as drugs.
- Why does this site show two separate labels?
- Because the two questions are independent. An evidence level tells you how strong the human research is for a specific claim; a regulatory status tells you what the FDA decided. Merging them hides exactly the information that matters most.
References
Numbered in order of first use. Study type is shown for every source; see our methodology for how we rank evidence.
- 1.
Drugs@FDA - FDA-approved drugs database U.S. Food and Drug Administration.
Regulatory source
Result: The searchable record of every FDA-approved drug, its approved indications, labels and approval dates.
↑ back to text - 2.
Understanding Unapproved Use of Approved Drugs "Off Label" U.S. Food and Drug Administration, 2018.
Regulatory source
Result: Explains that a prescriber may use an approved drug for an unapproved use when medically appropriate, and that off-label use is not FDA-evaluated for that use.
↑ back to text - 3.
Development & Approval Process | Drugs U.S. Food and Drug Administration.
Regulatory source
Result: Describes the evidence a sponsor must submit for the FDA to judge a drug's benefits outweigh its risks for a specific indication.
↑ back to text
Review status: Editorially reviewed against primary sources. This article was fact-checked against the primary sources listed in the references by our editorial team, and it has not been reviewed by a licensed clinician. It is educational content, not medical advice. Read our editorial policy and methodology. Spotted an error? Tell us.
